Ubs Asset Management Americas Inc Vericel Corp Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Vericel Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 96,371 shares of VCEL stock, worth $5.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,371

Previous 108,746 11.38%

Holding current value

$5.44 Million

Previous $4.99 Million 18.4%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.25 - $53.56 $522,843 - $662,805	-12,375 Reduced 11.38%	96,371 $4.07 Million
Q2 2024 Aug 13, 2024	BUY	$41.71 - $52.9 $2.23 Million - $2.83 Million	53,520 Added 96.91%	108,746 $4.99 Million
Q1 2024 May 15, 2024	BUY	$32.52 - $52.33 $85,332 - $137,313	2,624 Added 4.99%	55,226 $2.87 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $47,169 - $56,710	1,529 Added 2.99%	52,602 $1.87 Million
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $643,845 - $797,442	20,317 Added 66.06%	51,073 $1.71 Million
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $12,354 - $16,234	-518 Reduced 1.66%	30,756 $901,000
Q2 2022 Aug 12, 2022	SELL	$22.88 - $39.45 $221,226 - $381,442	-9,669 Reduced 23.62%	31,274 $787,000
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $3,059 - $3,943	-66 Reduced 0.16%	40,943 $2 Million
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $490,502 - $704,681	10,392 Added 33.94%	41,009 $2.15 Million
Q1 2021 May 14, 2021	BUY	$30.93 - $59.48 $35,198 - $67,688	1,138 Added 3.86%	30,617 $1.7 Million
Q4 2020 Mar 01, 2021	SELL	$18.53 - $31.5 $163,064 - $277,200	-8,800 Reduced 22.99%	29,479 $910,000
Q3 2020 Nov 13, 2020	SELL	$14.68 - $19.12 $8,881 - $11,567	-605 Reduced 1.56%	38,279 $709,000
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $90,414 - $168,277	-10,637 Reduced 21.48%	38,884 $537,000
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $7,511 - $19,911	1,036 Added 2.14%	49,521 $454,000
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $47,561 - $66,316	3,454 Added 7.67%	48,485 $843,000
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $101,777 - $135,181	6,817 Added 17.84%	45,031 $681,000
Q2 2019 Aug 15, 2019	BUY	$15.01 - $18.89 $396,474 - $498,960	26,414 Added 223.85%	38,214 $0
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $127,086 - $217,592	11,800 New	11,800 $205,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.5M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Vericel Corp Transaction History